Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
for Advanced Clear Cell Renal Cell Carcinoma
Drug: Ipilimumab
2 locations incl. Duarte
Sponsor: City of Hope Medical Center
Sex: All·Age: 18+
Code: NCT07128680·Phase 1·Recruiting